go-v.orgdoi

BRD7 inhibits tumor progression by positively regulating the p53 pathway in hepatocellular carcinoma

Changlong Chen, Huaqian Mo, Yanhui Jiang, Xiaohui Zhao, Shuang Ma, Kaiyun You, Yue Pan, Yimin Liu · Journal of Cancer · 2021

  • DOI 10.7150/jca.50293
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2021

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2021

Abstract

Background: Bromodomain-containing protein 7 (BRD7) is identified as a transcriptional regulator and plays an important role in the development and progression of various tumors.Our previous study demonstrated that BRD7 acts as a potential tumor suppressor in hepatocellular carcinoma (HCC).However, the specific molecular mechanism underlying the BRD7-mediated inhibition of HCC progression remains poorly understood.Methods: We performed ChIP-seq analysis to investigate the gene network mediated by BRD7.Immunohistochemical analysis was performed to analyze potential associations between the p53 and BRD7 expression and the effect of their overexpression on disease pathogenesis and outcome.In addition, we performed biological function experiments to determine the effect of BRD7 and p53 on these functions that are central to tumorigenesis.Finally, we employed a BALB/c model for execution of xenograft transplants to examine the effect of either overexpressing or under-expressing BRD7 and p53 on tumor growth in mice injected with cells.Results: Our results suggested that BRD7 regulates the p53 pathway.Specifically, BRD7 was demonstrated to upregulate the transcription level of p53 by directly binding to the upstream regulatory region of the p53 transcriptional initiation site, thereby enhancing its promoter activity.Moreover, immunohistochemical analysis showed that wild-type p53 (WTp53) expression is positively associated with BRD7 expression and survival of patients with HCC.Additionally,changes of p53 expression could affect the tumor suppressive role of BRD7 on HCC cell proliferation, migration/invasion, cell-cycle, and tumor growth in vitro and in vivo.Furthermore, changes of BRD7 expression in HCC cells significantly altered the expression of p53 signal-related molecules such as p21, Bax, Bcl2, and cyclin D1, indicating that BRD7 may positively regulate activation of the p53 pathway.Conclusions: Collectively, our results indicated that BRD7 exerts anti-tumor effects in HCC through transcriptionally activating p53 pathway.These critical roles of BRD7may provide some promising diagnostic and therapeutic targets for HCC.

Open the resolved locator · 10.7150/jca.50293

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 21:15 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v12p1507.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.